HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Lorus Therapeutics Announces Ohio State University Received a $2 Million US National Institutes of Health Grant to Evaluate Novel Nanoparticle Delivery Technology With Lorus' Oncology Drugs.
-
Internet Wire; Mar 24, 2009; 700+ Words
...via COMTEX) -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Corporation...researchers at the Ohio State University...for this study. Lorus agreed to supply...promise of siRNA therapeutics to effectively target...
-
-
Lorus Therapeutics announces presentation of GTI-2040 pharmacokinetic and metabolic data in acute myeloid leukemia.
-
PR Newswire; Oct 25, 2006; 700+ Words
...FirstCall/ -- Lorus Therapeutics Inc. ("Lorus") (TSX: LOR...management of cancer, announces the presentation...Medicine at The Ohio State University...collaboration of Lorus with Ohio State...development of novel therapeutics in cancer. Lorus...
-
-
Lorus Therapeutics announces new clinical trial of GTI-2040 in acute myeloid leukemia in sponsorship with the U.S. National Cancer Institute; - Expanding the clinical development of GTI-2040 -.
-
PR Newswire; Jul 7, 2003; 700+ Words
...FirstCall/ - Lorus Therapeutics Inc. ("Lorus") today announced...Guido Marcucci at Ohio State University...in Columbus, Ohio, selected GTI...executive officer, Lorus. "To now advance...1986, Lorus Therapeutics Inc. is a public...
-
-
Lorus Therapeutics announces presentation on GTI-2040 uptake by tumor cells in acute myeloid leukemia.
-
PR Newswire; Nov 1, 2006; 700+ Words
...FirstCall/ -- Lorus Therapeutics Inc. ("Lorus") (TSX: LOR...management of cancer, announces presentation...Executive Officer of Lorus. "The sophisticated...conducted at Ohio State University...development of novel therapeutics in cancer. Lorus...
-
-
Lorus Therapeutics announces third clinical trial with GTI-2040 in cooperation with the U.S. National Cancer Institute; - GTI-2040 in combination with docetaxel for the treatment of lung cancer -.
-
PR Newswire; Sep 15, 2003; 700+ Words
...lung cancer outcomes. Lorus also recently announced...is being conduced at Ohio State University Medical Center in Columbus, Ohio under the direction of...clinical trial. About Lorus Lorus is a biopharmaceutical...Founded in 1986, Lorus Therapeutics Inc. is a public company...
-
-
Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML).
-
PR Newswire; Jul 2, 2008; 700+ Words
...FirstCall/ -- Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" or the "Corporation...publication by an Ohio State University...Program (CTEP). Lorus is collaborating...development of novel therapeutics in cancer. Lorus...
-
-
Lorus Therapeutics announces third clinical trial with GTI-2040 in cooperation with the U.S. National Cancer Institute.
-
PR Newswire; Sep 15, 2003; 700+ Words
...lung cancer outcomes. Lorus also recently announced...is being conduced at Ohio State University Medical Center in Columbus, Ohio under the direction of...clinical trial. About Lorus Lorus is a biopharmaceutical...Founded in 1986, Lorus Therapeutics Inc. is a public company...
-
-
Lorus Therapeutics announces interim clinical results of GTI-2040 in combination chemotherapy for the treatment of renal cell cancer; - Further clinical development plans to proceed -.
-
PR Newswire; Jan 12, 2004; 700+ Words
Lorus Therapeutics Inc. ("Lorus") announced today interim results...Center; acute myeloid leukemia at the Ohio State University Medical Center and...and a variety of solid tumors. About Lorus Lorus is a biopharmaceutical company...
-
-
Lorus Therapeutics announces initiation of colon cancer trial with GTI-2040 in cooperation with the U.S. National Cancer Institute; -Novel drug combination enters clinical trial -.
-
PR Newswire; May 4, 2004; 700+ Words
...Therapeutics Inc. ("Lorus") announced today the...Jim Wright, CEO of Lorus Therapeutics Inc. "Overlapping toxicities...myeloid leukemia at the Ohio State University Medical...prostate cancer. About Lorus Lorus is a biopharmaceutical...
-
-
Lorus Therapeutics Inc. announces Phase III clinical trial progress with its lead immunotherapeutic drug, Virulizin(R); - Trial expanded to approximately 50 sites in North and Latin America -.
-
PR Newswire; Apr 16, 2003; 700+ Words
...PRNewswire-FirstCall/ - Lorus Therapeutics Inc. ('Lorus') today announced...Michigan, Louisiana, and Ohio. Details of the Phase...Jim Wright, CEO, Lorus. The US Food and Drug...Founded in 1986, Lorus Therapeutics Inc. is a public company...
-
-
Lorus announces international conference presentation of the clinical trial of GTI-2040 combined with high-dose Cytarabine in acute myeloid leukemia.
-
PR Newswire; Dec 12, 2005; 700+ Words
...PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical...Comprehensive Cancer Center at Ohio State University...Jim Wright, CEO of Lorus. He added: "in the...been completed. Lorus Therapeutics Inc. is a public company...
-
-
Lorus announces presentation of data from four clinical trials with three different drugs at the 2006 American Society of Clinical Oncology (ASCO) Meeting.
-
PR Newswire; Jun 1, 2006; 700+ Words
...PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical company...in survival. These data allow Lorus to further consider the clinical...investigator, Dr. Guido Marcucci of Ohio State University, will present...
-
-
Lorus announces results of Virulizin(R) Phase III Clinical Trial.
-
PR Newswire; Oct 18, 2005; 700+ Words
...PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical company...gemcitabine arm and the control group. Lorus thanks the patients, their caregivers...the Medical University of the Ohio Cancer Center, who participated...
-
-
Presentation at Pharmaceutical Scientists Meeting.
-
M2 Presswire; Nov 1, 2006; 700+ Words
...Exchange has brought Lorus, (AMEX:LRP) to...our research team. Lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX...management of cancer, announces presentation of GTI...studies are conducted at Ohio State University under...
|
|